Breast Cancer

Please read these Terms of Use and Privacy Statement (collectively, the "Terms") carefully before using any of the box above indicates that you accept these Terms.

Breast Cancer
x

Are you interested in exploring ongoing clinical trials for Breast Cancer at the University of Alabama at Birmingham?

Yes

Following specialists treat  Breast Cancer. Help us improve our data based on your experience.

Based on your feedback, we will add the specialty within 1 month


Submit

28%

100%

27%

45%

0%20%40%60%80%

Specialty scores for Breast Cancer

Overview

FDA Approved Medicines

  • FDA approved letrozole, sold as Femara, manufactured by Novartis as first-line treatment of postmenopausal women with locally advanced or metastatic breast cancer ( Breast Cancer ) in year 2001.
  • FDA approved pertuzumab, sold as Perjeta, manufactured by Genentech for the first-line treatment of HER2+ metastatic breast cancer ( Breast Cancer ) in year 2012.
  • FDA approved anastrozole, sold as Arimidex, manufactured by AstraZeneca for the treatment of advanced breast cancer in postmenopausal women ( Breast Cancer ) in year 1996.
  • FDA approved ixabepilone, sold as Ixempra, manufactured by Bristol-Myers Squibb for the treatment of breast cancer ( Breast Cancer ) in year 2007.
  • FDA approved lapatinib, sold as Tykerb, manufactured by GlaxoSmithKline for the treatment of breast cancer ( Breast Cancer ) in year 2007.
  • FDA approved palbociclib, sold as Ibrance, manufactured by Pfizer for the treatment of ER-positive, HER2-negative breast cancer ( Breast Cancer ) in year 2015.
  • FDA approved ado-trastuzumab emtansine, sold as Kadcyla, manufactured by Genentech for the treatment of HER2-positive metastatic breast cancer ( Breast Cancer ) in year 2013.
  • FDA approved fulvestrant, sold as Faslodex, manufactured by AstraZeneca for the treatment of hormone receptor positive metastatic breast cancer ( Breast Cancer ) in year 2002.
  • FDA approved Docetaxel, sold as Taxotere, manufactured by Rhone Poulenc Rorer for the treatment of locally advanced or metastatic breast cancer ( Breast Cancer ) in year 1996.
  • FDA approved eribulin mesylate, sold as Halaven, manufactured by Eisai for the treatment of metastatic breast cancer ( Breast Cancer ) in year 2010.
  • FDA approved pamidronate disodium for injection, sold as Aredia, manufactured by Chiron for the treatment of osteolytic bone metastases of breast cancer ( Bone Cancer | Breast Cancer ) in year 1996.